Viewing data from:

MIDODRINE HYDROCHLORIDE

ANDA

MIDODRINE HYDROCHLORIDE | A207613 | UNIQUE PHARMACEUTICAL LABORATORIES A DIV OF JB CHEMICALS AND PHARMACEUTICALS LTD

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.1469

per ea

Lowest NADAC/Unit

$0.0717

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
64980043501MIDODRINE HCL 10 MG TABLET	$0.1469	EA	Generic	—	2026-06-17
64980043401MIDODRINE HCL 5 MG TABLET	$0.1112	EA	Generic	—	2026-06-17
64980043301MIDODRINE HCL 2.5 MG TABLET	$0.0717	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain14 active DMFs3 inactive

14 active API suppliers hold Drug Master Files for this ingredient.

EDMOND PHARMA SRLMIDODRINE HYDROCHLORIDE

DMF 160172002

INDUSTRIALE CHIMICA SRLMIDODRINE HYDROCHLORIDE

DMF 160062002

TAPI NL BVMIDODRINE HYDROCHLORIDE, NON-STERILE, BULK DRUG SUBSTANCE

DMF 161352002

STERLING WISCONSIN LLCMIDODRINE HYDROCHLORIDE USP

DMF 164812003

APOTEX INCMIDODRINE HYDROCHLORIDE USP

DMF 184702005

IPCA LABORATORIES LTDMIDODRINE HYDROCHLORIDE USP

DMF 274642013

PH HEALTH LTDMIDODRINE HYDROCHLORIDE USP

DMF 282112014

TIANJIN WEIJIE PHARMACEUTICAL CO LTDMIDODRINE HYDROCHLORIDE BULK DRUG SUBSTANCE

DMF 302162016

ENALTEC LABS PRIVATE LTDMIDODRINE HYDROCHLORIDE USP

DMF 308062016

EMCURE PHARMACEUTICALS LTDMIDODRINE HYDROCHLORIDE USP

DMF 309902016

OPTIMUS DRUGS PRIVATE LTDMIDODRINE HYDROCHLORIDE

DMF 362722021

ZYDUS LIFESCIENCES LTDMIDODRINE HYDROCHLORIDE USP

DMF 378652022

DASAMI LAB PRIVATE LTDMIDODRINE HYDROCHLORIDE USP

DMF 398852024

MANKIND PHARMA LTDMIDODRINE HYDROCHLORIDE USP

DMF 404082024

NYCOMED AUSTRIA GMBHInactiveMIDODRINE HYDROCHLORIDE

DMF 63151986

CADILA HEALTHCARE LTDInactiveMIDODRINE HYDROCHLORIDE

DMF 156102001

CHEMAGIS LTDInactiveMIDODRINE HYDROCHLORIDE

DMF 164172003

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 2.5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Nov 2, 2018

No patent or exclusivity listings for this strength.

#002 — 5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 2, 2018

#003 — 10MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 2, 2018